BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10
• 11
• 12
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• Press Releases

  One Biosciences Receives BOOST Funding From Paris-Saclay Cancer Cluster to Advance the First Single-Cell Assay Approach for ADC Therapies

  June 23, 2026

   · 

  2 min read
• Press Releases

  MacroGenics to Receive Milestone Payment from Sanofi for Recent TZIELD® Approval

  June 23, 2026

   · 

  6 min read
• Press Releases

  Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

  June 23, 2026

   · 

  9 min read
• Press Releases

  Pioneering screening test offers potential to find more aggressive prostate cancers

  June 23, 2026

   · 

  3 min read
• Press Releases

  Kardigan Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

  June 23, 2026

   · 

  2 min read
• Press Releases

  Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions

  June 23, 2026

   · 

  5 min read
• Press Releases

  SoCalBio Unveils New Brand Reflecting Greater LA’s Growth as a Global Bioscience Hub

  June 23, 2026

   · 

  4 min read
• Press Releases

  Re:You Announces Preclinical Research Highlighting AI-Discovered Small Molecules Targeting Multiple Pathways of Hair Follicle Rejuvenation

  June 23, 2026

   · 

  1 min read
• 

  Policy

  BIO 2026: US public health as we know it is gone. Can we rebuild a better system?

  Former FDA, CDC and NIH leaders convene at the BIO International Convention to discuss the dismantling of the Department of Health and Human Services under the Trump administration—and where we go from here.

  June 23, 2026

   · 

  4 min read

   · 

  Jef Akst
• 

  Drug pricing

  BIO 2026: Biopharma dealmakers seek to protect ‘premium pricing’ from Trump’s MFN policy

  With drug pricing now embedded in U.S. policy, business development teams in biotech and pharma are changing the way they strike deals, including acknowledging policy uncertainties with renegotiation clauses.

  June 23, 2026

   · 

  2 min read

   · 

  Annalee Armstrong